Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.51 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.48 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | IGF2BP2 | Q9Y6M1 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7038969 | 0.99 | DHODH (0.50) | DHODHSERPINE1KDM4EACMSDNR1H4 | |
| Lithium Ion SCHEMBL7038967 | 0.89 | PPARG (0.60) | DHODHSERPINE1NR1H4NPC1RAB9A | |
| SCHEMBL7041709 | 0.88 | PLAU (0.52) | DHODHKDM4ENR1H4NPC1RAB9A | |
| SCHEMBL7039996 | 0.81 | DEGS1 (0.62) | KDM4ENR1H4NPC1RAB9APTPN1 | |
| SCHEMBL7038115 | 0.81 | IGF2BP2 (0.50) | SERPINE1ACMSDNR1H4NPC1RAB9A | |
| SCHEMBL7038149 | 0.80 | IGF2BP2 (0.49) | SERPINE1ACMSDNR1H4NPC1RAB9A | |
| SCHEMBL7033993 | 0.79 | NR1H4 (0.53) | DHODHSERPINE1KDM4EACMSDNR1H4 | |
| SCHEMBL7039689 | 0.78 | MAPT (0.55) | DHODHSERPINE1NR1H4NPC1RAB9A | |
| SCHEMBL8044197 | 0.77 | DHODH (0.79) | DHODHKDM4ENR1H4SLC16A3NPC1 | |
| SCHEMBL6357745 | 0.77 | DHODH (0.78) | DHODHKDM4ENR1H4SLC16A3NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030073862-A1 | Compounds | BIOVITRUM AB (SE) | 2003-04-17 | — | — | US | claimed |
| WO-2003004458-A1 | NEW COMPOUNDS | BIOVITRUM AB (SE) | 2003-01-16 | — | — | WO | claimed |
| WO-2003004458-A1 | NEW COMPOUNDS | BIOVITRUM AB (SE) | 2003-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073862-A1 | Compounds | PPARG, PPARA, PPARD | DHODH 2616/4885SERPINE1 1107/4885KDM4E 2125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.